J3403 – Revakinagene taroretcel-lwey, per implant
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ3403
- Long description
- Revakinagene taroretcel-lwey, per implant
- Short description
- Revakinagene, per implant
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- October 1, 2025
- Last change
- October 1, 2025 – No change
Frequently asked questions
What is HCPCS code J3403?
J3403 is a HCPCS Level II code for revakinagene taroretcel-lwey, per implant.
Does Medicare cover J3403?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J3394 – Injection, lovotibeglogene autotemcel, per treatment
- J3396 – Injection, verteporfin, 0.1 mg
- J3397 – Injection, vestronidase alfa-vjbk, 1 mg
- J3398 – Injection, voretigene neparvovec-rzyl, 1 billion vector genomes
- J3399 – Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes
- J3400 – Injection, triflupromazine hcl, up to 20 mg
- J3401 – Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml
- J3402 – Injection, remestemcel-l-rknd, per therapeutic dose
- J3404 – Injection, zopapogene imadenovec-drba suspension, per therapeutic dose
- J3405 – Injection, onasemnogene abeparvovec-brve, per treatment
- J3406 – Injection, omidubicel-onlv, per therapeutic dose
- J3410 – Injection, hydroxyzine hcl, up to 25 mg
- J3411 – Injection, thiamine hcl, 100 mg
- J3415 – Injection, pyridoxine hcl, 100 mg
- J3420 – Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
- J3424 – Injection, hydroxocobalamin, intravenous, 25 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.